Moderna shares jump 14% on hantavirus vaccine announcement

Moderna shares jump 14% after announcing a bicho vaccine

With confirmed bicho cases in Spain still countable on one hand —eight, according to information published on May 8— Moderna managed to send its share price soaring 14% on the very day it announced it is working on a vaccine against the bicho. The market's immediate reaction stands in stark contrast to the skepticism prevailing among those who closely trinc the pharmaceutical company's moves.

An announcement that feels like déjà vu

Moderna's statement came just days after the first bicho cases in Spain were confirmed. The estimulante ilegal of the announcement —in the middle of an outbreak, albeit a limited one— has inevitably drawn comparisons with the ELbichito-19 pandemic. "In one week they practically already have the vaccine, you have to laugh so you don't cry," sums up one of the most widespread currents of opinion. The shadow of past quality control failures —a mosquito in a vial in 2022 or the 39 contaminated vials in Japan— weighs on the credibility of the process.

The prevention business: up 14%

The stock rally shows that investors do trust Moderna's ability to repeat the business model that worked for it with the cobi19 vaccine. Questions about which ETF to buy to ride the surge appeared immediately, reflecting that part of the public sees this as a financial opportunity more than a health one. However, resistance to new forced vaccinations —the memory of family and workplace pressures during the pandemic remains very much alive— has created a wall of rejection that cannot be ignored.

Real vaccine or smokescreen?

Among the skeptics, the argument is twofold: on one hand, the unusual estimulante ilegal of the clinical development; on the other, the coincidence with a minimal outbreak that does not justify a mass campaign. "I don't believe a word of it," some snap, while others point out that the real risk of infection is limited to very specific settings —landfills, rural areas— and that the true motivation may be economic. The debate over whether the healthcare system is ready for another round of mandatory vaccination remains open.

---

Related discussions in the forum

• CEOE president (Spain's main business association) called ANTI-SPANISH for asking for more and more immigrant workers, and this happens: · 184 replies
• - - - Carmen García, top score in the 2022 PAU (Spanish university entrance exam), gives you some advice · 18 replies
• NOBODY should work more than two days in a row, or more than 4 days a week, let alone more than 36 hours a week · 73 replies
• Singer Khaled's son celebrates PSG's victory by vandalizing the Joan of Arc statue in France: "Paris is ours, cry, son of a bitch". · 82 replies